Altimmune

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Altimmune and other ETFs, options, and stocks.

About ALT

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. 

CEO
Jerome B. Durso
CEOJerome B. Durso
Employees
57
Employees57
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1997
Founded1997
Employees
57
Employees57

ALT Key Statistics

Market cap
382.28M
Market cap382.28M
Price-Earnings ratio
-3.42
Price-Earnings ratio-3.42
Dividend yield
Dividend yield
Average volume
2.39M
Average volume2.39M
High today
$3.21
High today$3.21
Low today
$2.80
Low today$2.80
Open price
$3.09
Open price$3.09
Volume
30.37M
Volume30.37M
52 Week high
$7.73
52 Week high$7.73
52 Week low
$2.80
52 Week low$2.80

Stock Snapshot

With a market cap of 382.28M, Altimmune(ALT) trades at $2.87. The stock has a price-to-earnings ratio of -3.42.

During the trading session on 2026-04-23, Altimmune(ALT) shares reached a daily high of $3.21 and a low of $2.80. At a current price of $2.87, the stock is +2.5% higher than the low and still -10.6% under the high.

Trading volume for Altimmune(ALT) stock has reached 30.37M, versus its average volume of 2.39M.

The stock's 52-week range extends from a low of $2.80 to a high of $7.73.

The stock's 52-week range extends from a low of $2.80 to a high of $7.73.

ALT News

TipRanks 24h
Altimmune announces common stock offering, no amount given

Altimmune (ALT) announced it has commenced an underwritten public offering of shares of its common stock and accompanying common stock warrants to purchase an e...

TipRanks 7d
Altimmune Stockholders Approve Proposals at 2026 Annual Meeting

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

82%

of 11 ratings
Buy
81.8%
Hold
9.1%
Sell
9.1%

People also own

Based on the portfolios of people who own ALT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.